Elixia

What Elixia does

Elixia, operating commercially under the Empathx brand, is a private, U.S.-based multi-specialty clinical research network founded in 2018 with 101-250 employees and headquarters in Hollywood, United States. The company delivers end-to-end clinical trial management and site operations for pharmaceutical sponsors and Contract Research Organizations across cardio-renal, cardio-metabolic (MASH, MASLD, diabetes, obesity), CNS/neurology/psychiatry, and infectious disease indications. Its operational model combines centralized clinical trial management systems and processes with local "embedded" site locations embedded within treating Nephrology practices, Dialysis units, and a distributed provider network structured as "Central Partners. Local Providers."

Core service offerings are organized around an End-to-End Solution for sponsors and CROs and a Patient Recruitment & Diversity program that the company reports consistently achieves >44% racial and 36%+ ethnic diversity enrollment across its sites. Therapeutic expertise is delivered through three productized programs: a Cardio-Metabolic program supporting 21 trials and 1,000+ randomized patients in obesity with complex comorbidities; a Cardio-Renal Network with over 30 years of combined investigator experience embedded in treating nephrology and dialysis settings; and a CNS/Neurology/Psychiatry program run in partnership with Beacon Health Partners' nationwide network of clinical psychiatrists. An Infectious Disease program targets immunocompromised and comorbid populations through dedicated researchers and treating physician investigators.

Commercial revenue is generated through professional-services contracts (clinical trial management, site operations, patient recruitment, diversity programs, and regulatory support) under a quote-based B2B enterprise model that is not publicly priced. Go-to-market is direct enterprise field sales to pharmaceutical sponsors and CROs, supplemented by digital channels (corporate website, LinkedIn, Facebook, YouTube, Instagram), industry events, and a patient participation portal. Pricing, contract values, and revenue figures are not disclosed; ownership, investor backing, and detailed leadership information are also not present in the source data, limiting visibility into capitalization and governance.

Name

Elixia

Legal name

Empathx

Website

https://elixiahealth.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

101–250 employees

Short description

Elixia (operating as Empathx) is a U.S. multi-specialty clinical research network founded in 2018 that delivers centralized trial management and embedded site operations across cardio-renal, metabolic, CNS/neurology/psychiatry, and infectious disease studies for pharmaceutical sponsors and CROs, with documented industry-leading diversity enrollment outcomes.

Ownership category

akta.pro rank

Product category

Clinical Research Services

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)

akta.pro secondary industry

Clinical Trial Pharmacy & IMP Management at Site (HLAGACAK)

Keywords

• Clinical trial management
• Patient recruitment services
• Diversity enrollment programs
• Clinical site operations
• Therapeutic expertise services

Headquarters

HQ city

Hollywood

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Research Services: Empathx provides end-to-end clinical trial management and site operations services to pharmaceutical sponsors and CROs, generating revenue through service contracts for patient recruitment, diversity programs, clinical site management, and regulatory support across cardiology, nephrology, psychiatry, neurology, metabolic, and infectious disease studies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Elixia (operating commercially as Empathx) is a multi-specialty clinical research site network that delivers centralized clinical trial management combined with embedded, community-first site operations for pharmaceutical sponsors and CROs. Its core services span study startup acceleration, patient recruitment and diversity enrollment, and therapeutic area expertise across cardio-renal, cardio-metabolic, psychiatry/neurology, metabolic, and infectious disease indications, supported by known patient pools within treating-physician practices and dialysis/nephrology units.

Product overview

Elixia (operating as Empathx) is a clinical research organization offering a unified platform of clinical site operations and trial management services. The portfolio consists of an End-to-End Solution for sponsors and CROs, combined with specialized Patient Recruitment & Diversity services. The company provides therapeutic expertise across key areas including CNS/Neurology/Psychiatry (via partnership with Beacon Health Partners), Metabolic conditions, Infectious Disease, and a Cardio-Renal Network. The platform leverages centralized systems and processes paired with local operations to accelerate study startup and enrollment, targeting underrepresented and underserved communities.

Differentiator

Problem solved

Functional benefit

Products and services

• End-to-End Solution Comprehensive end-to-end clinical trial management and operations service for pharmaceutical sponsors and CROs, providing study startup acceleration, centralized systems, and local operations to achieve rapid first patient in and high-quality data output across the network.
• Patient Recruitment & Diversity Specialized patient recruitment service for sponsors and CROs with a focus on equity and inclusion, with Empathx sites consistently enrolling over 44% racial and 36%+ ethnic diversity in clinical trials across therapeutic areas.
• CNS/Neurology/Psychiatry Therapeutic Expertise Clinical trial site and recruitment services in CNS, neurology, and psychiatry through a partnership with Beacon Health Partners' nationwide network of top clinical psychiatrists, bringing novel therapies to known patients of need across some of the most difficult-to-diagnose and enroll populations.
• Metabolic Therapeutic Expertise Clinical trial site services in metabolic indications including MASH, MASLD, diabetes, and obesity, with documented support for dozens of programs and 1,000+ randomized patients in obesity trials including complex comorbidities.
• Infectious Disease Therapeutic Expertise Clinical trial site services in infectious disease, delivered by dedicated researchers and treating physician investigators partnering with communities to deliver vaccines and treatments to immunocompromised and comorbid patient populations.
• Cardio-Renal Network Clinical research site network in cardio-renal indications combining over 30 years of experience with best-in-class sites embedded within treating Nephrology practices and Dialysis units, enabling the most complex indications within communities of unmet need.
• Cardio-Metabolic Program Clinical research services in cardio-metabolic indications built on decades of expertise and dozens of programs supported across MASH, MASLD, and diabetes, including 21 trials and 1,000+ randomized patients in obesity including complex comorbidities.

Quantifiable outcome

• >44% racial diversity enrollment and 36%+ ethnic diversity enrollment consistently achieved across sites
• +3 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Beacon Health PartnerscoreStrategic or Co-development PartnerEmpathx has a partnership with Beacon Health Partners' nationwide network of top clinical psychiatrists to bring novel therapies to known patients of need across difficult-to-diagnose and enroll populations in psychiatry and neurology. This partnership extends Empathx's reach in CNS/neurology/psychiatry indications.

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Fortrea (formerly LabCorp Drug Development): Fortrea is a global CRO offering end-to-end clinical trial services post-LabCorp spin-off. Comparable as a broad incumbent that competes with Empathx for pharma sponsor contracts and site-level execution work.
• Medpace: Medpace is a mid-to-large global CRO with strong therapeutic expertise in metabolic, cardiovascular, and CNS indications. Comparable to Empathx in therapeutic mix and as a sponsor-facing CRO competing for similar trials.
• PPD (Thermo Fisher Scientific): PPD, part of Thermo Fisher, is one of the world's largest CROs with global site management operations. Comparable as a broad incumbent competing for large-scale, multi-region sponsor trials.
• IQVIA: IQVIA is the largest global CRO and provides end-to-end clinical trial services including site management. Relevant as a broad incumbent competing for full-service sponsor contracts that Empathx would otherwise pursue.
• Syneos Health: Syneos Health is a global biopharmaceutical solutions organization offering clinical development and site management services. Comparable as a broad incumbent competing for sponsor site-management and full-service contracts.
• ICON plc: ICON is a global CRO offering comprehensive clinical development and site management services. Comparable as a broad incumbent competing for multi-region, full-service pharma trials that may include Empathx-style site partnerships.

Direct peers

• Velocity Clinical Research: Velocity is an integrated clinical research site network operating dedicated research facilities across multiple therapeutic areas. Directly comparable to Empathx as a multi-therapeutic SMO competing for the same pharma sponsor and CRO contracts.
• Flourish Research: Flourish Research operates an integrated network of clinical trial sites serving pharma sponsors across multiple therapeutic areas. Comparable to Empathx as an SMO pursuing similar patient-recruitment and diversity-led value propositions.
• CenExel Clinical Research: CenExel is a multi-therapeutic clinical research site network with embedded principal investigators across CNS, cardiometabolic, and other complex indications. Closely comparable to Empathx in operating model, therapeutic mix, and target customer base.
• Accel Research Sites: Accel is an integrated clinical research site network with multi-therapeutic coverage and dedicated site operations. Directly comparable to Empathx as an SMO competing in the same enterprise sales motion to pharma sponsors.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCI1uzJi-jWYToQxE9SaWTlQ/featured
• Facebookfacebook.com/ElixiaClinicalResearchCollaborative
• LinkedInlinkedin.com/company/elixia-clinical-research-collaborative
• Instagraminstagram.com/elixiaclinicalresearch

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elixia